Omada Health, Inc. (NASDAQ:OMDA – Get Free Report) President Wei-Li Shao sold 4,036 shares of the business’s stock in a transaction that occurred on Thursday, September 10th. The stock was sold at an average price of $21.85, for a total value of $88,186.60. Following the sale, the president directly owned 295,313 shares of the company’s stock, valued at $6,452,589.05. This represents a 1.35% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website.
Wei-Li Shao also recently made the following trade(s):
- On Wednesday, August 12th, Wei-Li Shao sold 8,866 shares of Omada Health stock. The stock was sold at an average price of $25.02, for a total transaction of $221,827.32.
Omada Health Price Performance
Shares of NASDAQ OMDA traded up $0.84 during mid-day trading on Monday, reaching $20.50. 961,447 shares of the company’s stock were exchanged, compared to its average volume of 1,250,359. The firm has a market capitalization of $1.26 billion, a price-to-earnings ratio of 410.00 and a beta of 1.86. The firm has a 50-day moving average price of $22.63 and a two-hundred day moving average price of $17.97. Omada Health, Inc. has a 52 week low of $10.28 and a 52 week high of $26.92.
Analysts Set New Price Targets
OMDA has been the subject of several research reports. Morgan Stanley reaffirmed an “overweight” rating and issued a $30.00 target price on shares of Omada Health in a research note on Monday, June 22nd. BTIG Research restated a “buy” rating and issued a $35.00 price target on shares of Omada Health in a research note on Friday. Wall Street Zen raised Omada Health from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. Citigroup reiterated an “outperform” rating on shares of Omada Health in a research note on Friday, August 14th. Finally, Robert W. Baird increased their target price on Omada Health from $15.00 to $25.00 and gave the company a “neutral” rating in a report on Wednesday, August 12th. Eleven analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $26.67.
Get Our Latest Stock Analysis on OMDA
Institutional Investors Weigh In On Omada Health
A number of institutional investors and hedge funds have recently added to or reduced their stakes in OMDA. WINTON GROUP Ltd purchased a new stake in Omada Health during the second quarter worth $1,101,000. Integrated Wealth Concepts LLC purchased a new position in shares of Omada Health during the second quarter worth $53,000. Squarepoint Ops LLC acquired a new position in shares of Omada Health in the 2nd quarter valued at about $2,044,000. Corient Private Wealth LP boosted its position in Omada Health by 252.5% in the 2nd quarter. Corient Private Wealth LP now owns 145,118 shares of the company’s stock worth $3,185,000 after purchasing an additional 103,955 shares in the last quarter. Finally, California State Teachers Retirement System raised its position in shares of Omada Health by 465.1% in the second quarter. California State Teachers Retirement System now owns 10,229 shares of the company’s stock worth $225,000 after acquiring an additional 8,419 shares during the period.
Omada Health Company Profile
Omada Health, Inc is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines clinical care, health coaching, connected devices, digital tools and personalized support to help members improve health outcomes and manage conditions over time.
The company’s offerings address areas including diabetes, hypertension, weight health and musculoskeletal conditions. Omada’s programs are designed to support prevention and ongoing care through services such as remote monitoring, personalized health guidance, educational content and access to healthcare professionals.
Omada primarily serves members through employers, health plans and healthcare organizations in the United States.
Featured Stories
- Five stocks we like better than Omada Health
- Analysts Are Punting Their Calls Into the Next Quarter After Adobe’s Mixed Earnings
- Institutional Money Is Pouring Into These 2 Altcoin ETFs
- The End of Big Tech Buybacks? Only One Hyperscaler Is Still Repurchasing Shares
- 3 Dividend Kings to Buy While They’re Still Beaten Down
Receive News & Ratings for Omada Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omada Health and related companies with MarketBeat.com's FREE daily email newsletter.
